Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A metabolic disorder resulting from defective renal tube reabsorption of proline, hydroxyproline and glycine. The prevalence is estimated at around 1 in 15 000. The disorder is usually asymptomatic and is identified fortuitously by detection of increased levels of the imino acids and glycine in the urine. It is transmitted as an autosomal recessive trait.
Features include: Prolinuria, Hydroxyprolinuria, Hyperglycinuria, and Intellectual disability and 1 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 1 | Intellectual disability |
Eyes | 1 | Abnormality of the eye |
SLC36A2 function has not been fully characterized.
Iminoglycinuria has limited evidence linking it to mutations in the SLC36A2 gene on chromosome 5.
Genetic testing for SLC36A2 is available. Testing is considered research-grade for diagnosis.
Estimated prevalence: 1-9 in 100,000 (Uncommon).
No clinical trials have been registered for iminoglycinuria.
1 publication has been identified in PubMed for iminoglycinuria. Research spans Basic Science / Preclinical (100%).
Li HZ (2024). [PMID: 38951531](https://pubmed.ncbi.nlm.nih.gov/38951531/). *Nat Commun*. [Basic Science / Preclinical]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 6:42 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center